NFE2L2 and cancer: Nrf2, once regarded as a potential key to unlock novel therapies in the cardiovascular and cancer fields, has now assumed the role of a double-edged sword: when properly regulated, it can reduce ROS and increase wound healing but carries the possibility of chemotherapy resistance and cardiomyopathy when overexpressed by exogenous manipulation through natural and synthetic compounds.